Seyed Milad Safar Sajadi

ORCID: 0009-0002-1825-7077
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Pigment Synthesis and Properties
  • Animal Virus Infections Studies
  • Conducting polymers and applications
  • Organic Electronics and Photovoltaics
  • Luminescence and Fluorescent Materials
  • Advanced Photocatalysis Techniques
  • Supramolecular Chemistry and Complexes
  • Porphyrin and Phthalocyanine Chemistry
  • TiO2 Photocatalysis and Solar Cells
  • Organic Light-Emitting Diodes Research
  • Nanomaterials for catalytic reactions
  • Copper-based nanomaterials and applications

University of Tehran
2021

Baqiyatallah University of Medical Sciences
2019

Islamic Azad University of Gorgan
2019

University of Isfahan
2015

Aggregation-induced quenching of porphyrin molecules as photosensitizer significantly reduces the quantum yield singlet oxygen generation, and it is able to decrease efficacy photodynamic therapy. We utilized amphiphilic copolymers in this work precisely control H-type J-type aggregations water. The copolymer bearing azobenzene, β-cyclodextrin, was successfully synthesized by atom transfer radical polymerization technique. azobenzene β-cyclodextrin complex, a host-guest supramolecular...

10.1038/s41598-021-82256-7 article EN cc-by Scientific Reports 2021-02-02

At the forefront of biopharmaceutical industry, messenger RNA (mRNA) technology offers a flexible and scalable platform to address urgent need for world-wide immunization in pandemic situations. This strategic powerful has recently been used immunize millions people proving both safety highest level clinical efficacy against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we provide preclinical report COReNAPCIN®; vaccine candidate SARS-CoV-2 infection....

10.1038/s41541-022-00528-3 article EN cc-by npj Vaccines 2022-09-02

At the forefront of biopharmaceutical industry, messenger RNA (mRNA) technology offers a flexible and scalable platform to address urgent need for world-wide immunization in pandemic situations. This strategic powerful has recently been used immunize millions people proving both safety highest level clinical efficacy against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we provide preclinical report COReNAPCIN ® ; vaccine candidate SARS-CoV-2 infection. is...

10.1101/2022.03.05.483092 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2022-03-07
Coming Soon ...